91ÑÇÉ«´«Ã½

Annual Meeting

Phthalate alternative may harm brain development and health

Acetyl tributyl citrate, a leading phthalate alternative, found to disrupt neuron-like cells
Anne Frances Johnson
March 27, 2023

Growing concerns over the potential health effects of exposure to phthalates, a component of many plastics and also known as a plasticizer, have led to a search for safer alternatives. In a new study conducted in cell cultures, researchers found that the chemical acetyl tributyl citrate (ATBC) might not be the best replacement because it appears to interfere with the growth and maintenance of neurons.

“In the past, industries have promptly shifted away from the usage of toxic chemicals only to produce an equally toxic chemical, so this is something we are actively trying to avoid repeating,” said Kyle Sease, a graduate student at Central Washington University in Ellensburg, Washington. “Our study suggests that ATBC, but not other non-phthalate alternatives, could interfere with cells that maintain brain health. We think this finding warrants further testing of ATBC at different doses, in different settings and in whole organism models.”

Sease will present the new research at , the annual meeting of the 91ÑÇÉ«´«Ã½, March 25–28 in Seattle.

Phthalates are used in hundreds of products, often to enhance durability or allow materials to bend and stretch. Studies have shown that phthalate exposure can affect the reproductive system and early development in a range of animals, although the health impacts in humans are not clear. ATBC has emerged as a leading phthalate alternative as companies seek to shift away from phthalates and is currently used in a variety of materials and products, including food and food packaging.

For the study, researchers grew cultures of neuroblastoma cells, which, in terms of growth and division, behave similarly to the glial cells that support and protect neurons in the brain. They then used molecular methods to study how ATBC and other chemicals affect genes and processes involved in cellular division. They found that neuroblastoma cells exposed to ATBC increased their expression of two genes associated with cellular stress (known as Nrf2 and p53) and also increased their production of an enzyme associated with cellular senescence (B-galactosidase), which can cause cells to stop growing and dividing.

The findings suggest that ATBC could interfere with the ability for glial cells to regenerate, which can reduce their ability to protect neural cells and lead to neurodegeneration and accelerated aging. It is also possible that ATBC exposure during early development — when neurons are actively growing and dividing — could affect neurons directly and interfere with brain development, the researchers said. Since neurons do not typically regrow once damaged, any effects on the brain likely would be permanent. 

Two other phthalate alternatives, bis (2-ethylhexyl)-1, 4-benzenedicarboxylate (GPO) and dioctyl adipate (DOA), did not show the same effects as ATBC. “We found that two other plasticizers did not appear to affect cell division in these cells, so further understanding the different effects of different plasticizers will allow us to understand better how to make safe ones,” Sease said.

Kyle Sease will present this research from 4:30–6:30 p.m. PDT on Monday, March 27, in Exhibit Hall 4AB of the Seattle Convention Center (Poster Board No. 141) (). Contact the media team for more information or to obtain a free press pass to attend the meeting.

Enjoy reading 91ÑÇÉ«´«Ã½ Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Anne Frances Johnson

Anne Frances Johnson is founder and lead science writer at based in Chapel Hill, North Carolina. 

Get the latest from 91ÑÇÉ«´«Ã½ Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

New discovery enables gene therapy for muscular dystrophies, other disorders
News

New discovery enables gene therapy for muscular dystrophies, other disorders

Dec. 28, 2024

At the University of Rochester, researchers find that RNA-based technology facilitates effective use for difficult-to-treat, large-gene diseases.

From the journals: JBC
Journal News

From the journals: JBC

Dec. 27, 2024

Huntington protein interactions affect aggregation. Intrinsically disordered protein forms a scaffold. From unknown protein to curbing cancer growth. Read about recent JBC papers on these topics.

An inclusive solar eclipse — with outreach
Essay

An inclusive solar eclipse — with outreach

Dec. 26, 2024

Traveling more than 150 miles with a group of neurodivergent students to have them witness a rare orbital alignment. and also teach the public about it, requires some strategic planning.

Predicting fatty liver disease from a tiny blood sample
Journal News

Predicting fatty liver disease from a tiny blood sample

Dec. 24, 2024

Obesity and being overweight aren't the only factors that contribute to liver disease. New tests can help identify who is at risk or already has the disease, even in people who are lean or have a normal weight.

An ancient animal helps scientists improve modern technology
News

An ancient animal helps scientists improve modern technology

Dec. 22, 2024

The same molecules that help tardigrades survive extreme weather can improve cryo-EM images of cellular structures and proteins, a team led by University of Wisconsin–Madison researcher Ci Ji Lim reports.

New structure gives insight into mRNA export and cancers
News

New structure gives insight into mRNA export and cancers

Dec. 21, 2024

Yi Ren’s lab at Vanderbilt has described the structure of a protein complex that sheds light on the underlying molecular mechanism of mRNA export.